InvoCare Released Chairman’s Presentation To Shareholders

InvoCare Released Chairman’s Presentation To Shareholders

The Annual General Meeting of InvoCare Limited (ASX: IVC) was held on 14th May 2019, where the Chairman addressed to the shareholders. The Chairman highlighted the financial performance of the company in 2018. Operating performance in FY18 was impacted by unusual market conditions and location renovations due to which operating earnings were down 22.1% to $49.5 million, and statutory profit after tax also posted a de-growth of 57.7% to $41.2 million. However, management believes that the fundamentals of demand remain strong. Coming to the dividend distribution, the company continues its long-standing practice of a dividend pay-out ratio of more than 75% of operating earnings after tax.

On equity raising part, the company has raised circa $93 million in March/April 2019, of which the underwritten institutional placement was ~$65 million, SPP (Share Purchase Plan) was $23 million and DRP (Dividend Reinvestment Plan) was $4 million. The issue price for the equity raising was $14.00, which was more than 2.5% discount to share price immediately before this equity raising. With the combination of underwritten placement and SPP was put in place by the company for maximum certainty and minimum dilution. Funds raised from such activity will be used to maintain momentum in growth strategies and to strengthen the balance sheet. The Chairman acknowledged the strong support from the shareholders.

Performance Summary of 2018: Revenue growth in 2018 was up just 1.4% to $477.3 million with total expenses amounted to $361.2 million, grew 3.3% in FY18, driving operating EBITDA to $119 million with 4.3% de-growth. Operating earnings after tax came in at $49.5 million, which also saw a de-growth of 22.1% in FY18. Operating margins were down by 150 bps.

The company’s improved safety measures have resulted in a 2.3% decrease in the number of deaths for the company in FY18. As previously indicated, this is at the higher end of a decline, which was previously experienced. Funeral case average decreased by 0.3%, driven by the competitive pricing for the traditional brands. IVC anticipates the number of deaths to increase Y-o-Y (year on year) in 2019.

The company measures customer satisfaction using NPS (Net Promoter Score), which stood at +74 as of December 2017. IVC has implemented various steps taken, including investment in locations through Protect & Grow, launching of customer service reward scheme for operational staff, improvement in service proposition and brand standards and customer service master classes with 1,400 attendees. These steps have enabled IVC to achieve NPS score of +79 as of December 2018.

Q1 Performance Update: The number of deaths have begun to revert to the long-term trend, as suggested in February 2019. This rise along with the effect of 2018 acquisitions have resulted in a strong performance for 1Q FY19. The improved trading experienced in the early part of the year continued to prevail in Q1 FY19, and IVC achieved a sales growth of 7.8%, with operating EBITDA growth of 22.2%. The operating margin expanded by 2.5 ppts with operating earnings after tax at increasing by 9% over pcp.


At market close on 14th May 2019, the stock of IVC was trading at price of $15.220, up 4.175% with a market cap of $1.71 billion.


This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report